Guar Gum Futures Rise on Demand

By By Rediff Money Desk, New Delhi
Oct 01, 2025 16:03
Guar gum futures climb on firm spot demand. November contracts up Rs 48 to Rs 8,822/quintal on NCDEX. Analysts cite physical market trend.
New Delhi, Oct 1 (PTI) Guar gum prices on Wednesday rose Rs 48 to Rs 8,822 per quintal in futures trade as speculators increased their holdings amid a firm spot demand.

On the National Commodity and Derivatives Exchange, guar gum contracts for November delivery traded higher Rs 48 or 0.54 per cent at Rs 8,822 per quintal with an open interest of 25,195 lots.

Analysts said after tracking a firm physical market trend, traders raised their bets, which led to the rise in guar gum prices.
Source: PTI
Read More On:
guar gumfutures tradedemandncdexprices
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Corona Remedies IPO Subscribed 137 Times

Corona Remedies IPO subscribed 137.04 times on final day. QIBs subscribed 278.52 times,...

India Logistics Cost Down to 9%: Gadkari

Nitin Gadkari says India has met its target to reduce logistics cost to 9% of GDP due...

Coal Mining: Panel Urges Faster Green Clearances

Parliamentary panel urges faster environmental & forest clearances for coal mining...

DCM Shriram & Bayer Crop Science Collaboration

DCM Shriram and Bayer Crop Science partner to explore agricultural opportunities in...

Silver Price Soars to Rs 1.92 Lakh/kg on Global...

Silver prices surge Rs 11,500 to Rs 1.92 lakh/kg in Delhi amid strong global cues. Gold...

Urea Fixed Costs to Rise for Manufacturers

Govt plans to raise fixed costs for urea makers by year-end. Decision expected soon,...

Bullion Rates Today: Gold & Silver Prices

Check today''s closing bullion rates in Bengaluru. Gold (22K & 24K) prices per gram and...

Bank of India Raises Rs 2,500 Cr via Tier II Bonds

Bank of India (BoI) raised Rs 2,500 crore through Basel III-compliant Tier II bonds at...

Cipla Launches Obesity & Diabetes Drug Yurpeak

Cipla launches Yurpeak (tirzepatide), a weekly injectable for obesity and type-2...

Sebi Eases KYC for NRIs, Removes Physical Presence

Sebi relaxes re-KYC for NRIs, removing physical presence requirement for digital...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com